Citation 87290

SU,BN: CUENDET,M: HAWTHORNE,ME: KARDONO,LBS: RISWAN,S: FONG,HHS: MEHTA,RG: PEZZUTO,JM: KINGHORN,AD:. (2002). CONSTITUENTS OF THE BARK AND TWIGS OF ARTOCARPUS DADAH WITH CYCLOOXYGENASE INHIBITORY ACTIVITY.. 65(2)

Citation Details

Title	CONSTITUENTS OF THE BARK AND TWIGS OF ARTOCARPUS DADAH WITH CYCLOOXYGENASE INHIBITORY ACTIVITY.
Authors	SU,BN: CUENDET,M: HAWTHORNE,ME: KARDONO,LBS: RISWAN,S: FONG,HHS: MEHTA,RG: PEZZUTO,JM: KINGHORN,AD:
Year	2002
Volume	65
Issue	2

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (2)

Artocarpus dadak (MORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CATECHIN,(+):	None
4	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
5	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	WEAK ACTIVITY
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	None
8	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	ACTIVE
9	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	INACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESVERATROL,3-(GAMMA-GAMMA-DIMETHYL-ALLYL):	None
12	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(GAMMA-GAMMA-DIMETHYL-ALLYL):	ACTIVE
13	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(GAMMA-GAMMA-DIMETHYL-ALLYL):	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(GAMMA-GAMMA-DIMETHYL-ALLYL):	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	None
16	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
17	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RESVERATROL,OXY:	None
20	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	ACTIVE
21	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	EQUIVOCAL
23	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESVERATROL,OXY: 5-(GAMMA-GAMMA-DIMETHYL-ALLYL):	None
24	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY: 5-(GAMMA-GAMMA-DIMETHYL-ALLYL):	ACTIVE
25	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY: 5-(GAMMA-GAMMA-DIMETHYL-ALLYL):	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY: 5-(GAMMA-GAMMA-DIMETHYL-ALLYL):	INACTIVE
27	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESVERATROL,3-(2-3-DIHYDROXY-3-METHYL-BUTYL):	None
28	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(2-3-DIHYDROXY-3-METHYL-BUTYL):	ACTIVE
29	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(2-3-DIHYDROXY-3-METHYL-BUTYL):	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,3-(2-3-DIHYDROXY-3-METHYL-BUTYL):	INACTIVE
31	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MORIN,DIHYDRO:	None
32	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN,DIHYDRO:	ACTIVE
33	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN,DIHYDRO:	INACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN,DIHYDRO:	ACTIVE
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AFZELECHIN(4-BETA-8)-EPI-CATECHIN,EPI:	None
36	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN(4-BETA-8)-EPI-CATECHIN,EPI:	ACTIVE
37	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN(4-BETA-8)-EPI-CATECHIN,EPI:	INACTIVE
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN(4-BETA-8)-EPI-CATECHIN,EPI:	INACTIVE

Artocarpus dadak (MORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DADAHOL B	None
4	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DADAHOL B	INACTIVE
5	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DADAHOL B	INACTIVE
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DADAHOL A	None
7	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DADAHOL A	INACTIVE
8	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DADAHOL A	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	None
10	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
11	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M,3-(GAMMA-GAMMA-DIMETHYL-PROPENYL):	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RESVERATROL	None
14	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
15	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STEPPOGENIN	None
18	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEPPOGENIN	ACTIVE
19	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEPPOGENIN	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STEPPOGENIN	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CATECHIN,(+):	None
22	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
23	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	WEAK ACTIVITY
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RESVERATROL,OXY:	None
26	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	ACTIVE
27	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	ACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,OXY:	ACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MORACIN M	None
30	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M	ACTIVE
31	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M	EQUIVOCAL
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARTOCARPETIN,NOR:	None
34	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	ACTIVE
35	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	INACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARTOCARPETIN,NOR:	ACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	None
38	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	ACTIVE
39	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELECHIN-3-O-ALPHA-L-RHAMNOPYRANOSIDE	INACTIVE
41	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ENGELETIN	None

Citation 87290

Citation Details

Summary

Organisms and Their Experiments (2)

Artocarpus dadak (MORACEAE)

Artocarpus dadak (MORACEAE)

Show SPARQL Queries (1)

Query 1